SPY330.06+1.27 0.39%
DIA268.41+1.69 0.63%
IXIC10,941.17+38.37 0.35%

B. Riley FBR Maintains Buy on Arrowhead Pharmaceuticals, Raises Price Target to $59

B. Riley FBR maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Buy and raises the price target from $46 to $59.

Benzinga · -

B. Riley FBR maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Buy and raises the price target from $46 to $59.